Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Yoga Cancer Rehabilitation Study: A Randomized Trial of Adaptive Yoga for Older Cancer Survivors (YogaCares)

This study has been completed.
Wake Forest School of Medicine
Information provided by (Responsible Party):
VA Office of Research and Development Identifier:
First received: March 4, 2011
Last updated: December 3, 2015
Last verified: December 2015
Results First Received: December 2, 2014  
Study Type: Interventional
Study Design: Allocation: Randomized;   Endpoint Classification: Safety/Efficacy Study;   Intervention Model: Single Group Assignment;   Masking: Open Label;   Primary Purpose: Treatment
Condition: Neoplasms
Intervention: Behavioral: Yoga therapy

  Participant Flow
  Hide Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
Participants identified through cancer registry who were: diagnosed with cancer (any type) Stage 1-4 within the past three years; received surgery, chemotherapy, or radiation treatment; no psychotic or dementing disorders; and not currently in hospice care.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
No participants were excluded prior to assignment.

Reporting Groups
Yoga Therapy Intervention


Yoga therapy received an 8 week 2x weekly Yoga therapy class.

Wait List Control Wait List control received no intervention for 8 weeks, then joined the yoga group

Participant Flow:   Overall Study
    Yoga Therapy Intervention   Wait List Control
STARTED   11 [1]   12 [2] 
COMPLETED   10   6 
illness                1                6 
[1] Yoga groups 3 and 5 (not including pre-randomization group)
[2] Yoga group 4 and 6

  Baseline Characteristics
  Hide Baseline Characteristics

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
No text entered.

Reporting Groups
Yoga Therapy Intervention Intervention: Yoga therapy was 8 week class for two times per week
Wait List Control Wait List control: The wait list control did not receive an intervention.
Total Total of all reporting groups

Baseline Measures
    Yoga Therapy Intervention   Wait List Control   Total
Overall Participants 
[units: participants]
 11   12   23 
Age, Customized [1] 
[units: Years]
Mean (Full Range)
Mean   69.42 
 (55 to 84) 
 (55 to 84) 
 (55 to 84) 
[1] Adult individuals of any age were permitted, but since most of those diagnosed with cancer are older, the sample is predominantly older.
[units: participants]
Female   1   0   1 
Male   10   12   22 
Race/Ethnicity, Customized 
[units: participants]
Caucasian   10   11   21 
All other   1   1   2 

  Outcome Measures

1.  Primary:   Patient-Reported Outcomes Measurement System Scale, a Scale Developed by the National Institute of Health to Assess Outcomes Across Different Trials.   [ Time Frame: Primary outcome is measured at baseline and after the 8 week yoga intervention. ]

  Serious Adverse Events

  Other Adverse Events

  Limitations and Caveats
  Hide Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
The goals of this study were modest. A small pilot pre-post randomized trial was completed with a Yoga therapy intervention and a Wait list intervention. Additional studies in larger samples are needed.

  More Information
  Hide More Information

Certain Agreements:  
All Principal Investigators ARE employed by the organization sponsoring the study.

Results Point of Contact:  
Name/Title: Jennifer Moye
Organization: VA Boston Healthcare System
phone: 774-826-3721


Responsible Party: VA Office of Research and Development Identifier: NCT01324102     History of Changes
Other Study ID Numbers: D7629-P
Study First Received: March 4, 2011
Results First Received: December 2, 2014
Last Updated: December 3, 2015
Health Authority: United States: Federal Government